QUADRATEK data solutions has announced the expansion of its European service and support offerings through the enlargement of their presence in Berlin, Germany. London, Berlin, July, 2008 QUADRATEK data solutions Ltd., a UK-based provider of e-clinical solutions, has announced the expansion of its European service and support offerings through the enlargement of their presence in Berlin, Germany. QUADRATEK is the creator of clincase, a fully featured electronic data capture (EDC) and clinical data management (CDM) software solution for clinical trials. The company’s decision came as a response to the growing demand for additional service and support offerings around the software. Henning Lux, CEO and Managing Director of QUADRATEK data solutions said: “with the expansion of our branch in Berlin we are extending our service portfolio as well as our sales and marketing structure which gives US additional resources to provide a wider range of services to our customers than ever before.” clincase has been developed at offices in the United Kingdom and Berlin to be implemented as to EDC solution for contract research organizations (CROs) and pharmaceutical companies.

With the new additional resources for software development, sales and marketing in its Berlin office, QUADRATEK wants to put strong emphasis on enhanced customer services and support. About QUADRATEK data solutions Ltd. QUADRATEK data solutions is the clinical software development division of the QUADRATEK group which operates a number of diverse IT businesses including consultancy, development and secure data hosting services. QUADRATEK has particular specialist knowledge of the defence, medical and life science, pharmaceutical, finance and local and Central Government channels. The company which established in 1997. QUADRATEK data solutions has created clincase, a complete software solution for data management in clinical trials. Clincase provides unmatched user experience in study design, electronic data capture (EDC) and clinical data management (CDM). As on off-the-shelf solution with open architecture it is ideally suited for integration with existing clinical trial processes and infrastructure.